EcoDrugPlus

Mast/stem Cell Growth Factor Receptor Kita-Like

Ensembl ID : ENSHBUG00000014002
Gene Symbol: LOC102294412
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSHBUG00000020157
Gene Symbol: MMP14
3 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSHBUG00000023687
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSHBUG00000022457
Gene Symbol: MMP9
3 Cross references
214 Possible Orthologues:

Matrix Metalloproteinase-14-Like

Ensembl ID : ENSHBUG00000002951
Gene Symbol: LOC102310167
3 Cross references
196 Possible Orthologues:

Matrix Metalloproteinase-20-Like

Ensembl ID : ENSHBUG00000004971
Gene Symbol: LOC102314660
2 Cross references
163 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSHBUG00000019711
Gene Symbol: MTOR
3 Cross references
216 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSHBUG00000015850
Gene Symbol: MC1R
2 Cross references
159 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSHBUG00000013950
Gene Symbol: MC4R
1 Cross references
89 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSHBUG00000010485
Gene Symbol: MTNR1A
3 Cross references
186 Possible Orthologues:

Membrane Metalloendopeptidase

Ensembl ID : ENSHBUG00000015067
Gene Symbol: MME
4 Cross references
231 Possible Orthologues:

Metabotropic Glutamate Receptor 2-Like

Ensembl ID : ENSHBUG00000001898
Gene Symbol: LOC102293176
3 Cross references
206 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).